Pmm2 Cdg clinical trials

Explore recruiting pmm2 cdg clinical trials.

Also recruiting in Europe

Pmm2 Cdg trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2b, Multicenter, Double-blind, Randomized, Placebo controlled Study to Assess the Efficacy and Safety of Weekly Doses of GLM101 Administered Intravenously to Participants with PMM2-CDG

Italy, Poland, Czechia, France, Spain, Portugal +2 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2, Randomized, Open-Label, 24-Week Study to Assess the Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Multiple Doses of GLM101 Administered Intravenously to Adult, Adolescent and Pediatric Participants with PMM2-CDG

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2, Open-Label Extension Study to Assess the Safety and Efficacy of GLM101 Administered Intravenously to Participants with PMM2-CDG

Spain, Portugal, Czechia, Italy, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Pmm2 Cdg trials by city

Pmm2 Cdg in Toronto Pmm2 Cdg in Vancouver Pmm2 Cdg in Montreal Pmm2 Cdg in Calgary Pmm2 Cdg in Edmonton Pmm2 Cdg in Ottawa Pmm2 Cdg in Winnipeg Pmm2 Cdg in Quebec City Pmm2 Cdg in Hamilton Pmm2 Cdg in Kitchener Pmm2 Cdg in London Pmm2 Cdg in Halifax Pmm2 Cdg in New York Pmm2 Cdg in Los Angeles Pmm2 Cdg in Chicago Pmm2 Cdg in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease